SURF — Surface Oncology Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- $65.08m
- $8.82m
- $30.00m
U.S. STOCKS ON THE MOVE-UniQure, Select Energy Services, Service Corporation International
Surface Oncology posts quarterly loss; shares down and reports lay-offs
Surface Oncology Inc reports results for the quarter ended in September - Earnings Summary
Brief: Surface Oncology Announces SRF388 Monotherapy Data In Non-Small Cell Lung Cancer
Surface Oncology Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: VIB And Surface Oncology Announce Publication In Cell Reports Revealing Il-27 Structure And The Mechanism Of Action For Srf388
Brief: Surface Oncology Inc- Cash Sufficient To Fund Operations Into 2024
Brief: Surface Oncology Appoints Carsten Brunn To Board Of Directors
Brief: Surface Oncology Announces Publication Of New Study Demonstrating The Role Of The IL-27 Pathway In Hepatocellular Carcinoma
Brief: Surface Oncology To Present New Srf388 Clinical Data At 2022 American Society Of Clinical Oncology (Asco) Annual Meeting
U.S. STOCKS ON THE MOVE-Tesla, JD, Boeing, Palantir, Shopify
U.S. STOCKS ON THE MOVE-Rivian, Boeing, banks, Big Tech
U.S. STOCKS ON THE MOVE-Shaw Communications, Shopify, Palantir, Rivian
Surface Oncology gains on Q1 profit, cash runway
Brief: Surface Oncology Reports Financial Results And Corporate Highlights For First Quarter 2022
Brief: Surface Oncology Inc Posts QTRLY Diluted Net Income Per Share Of $0.13
Surface Oncology Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Surface Oncology Initiates Phase 2 Studies Evaluating SRF388
U.S. STOCKS ON THE MOVE-Baidu, Clarus, cruise operators